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The following thesis will be divided into two main sections. Chapter 1 will serve as a review 





Inflammation and oxidative stress as links between chronic stress and 








Cardiovascular disease remains the leading cause of death worldwide. Apart from known risk factors 
such as poor dietary intake, physical inactivity and smoking, chronic psychological stress is emerging 
as an important modifiable risk factor in the development of cardiovascular disease. The body relies on 
two physiological mechanisms to counter acute stressors and to achieve and/or maintain homeostasis, 
i.e. the hypothalamic-pituitary-adrenal axis and the autonomic nervous system. However, chronic 
activation of these systems can lead to the disruption of cellular and systemic processes that could 
potentially result in the development of neurological or psychosomatic diseases. Both chronic stress 
and ischemia-reperfusion injury are associated with a robust inflammatory response and the induction 
of oxidative stress. Does chronic psychological stress render the heart more susceptible to ischemia and 
reperfusion damage, and what are the role(s) of oxidative stress and inflammation in stress-related 
cardiac dysfunction?  These questions will form the basis of this review. Following a comprehensive 
review, we established that chronic stress does render the heart more susceptible to damage following 
ischemia-reperfusion. After reviewing the mechanisms involved in both ischemia-reperfusion and 
chronic stress, we hypothesized that chronic stress induced inflammation and oxidative stress are major 








Kardiovaskulêre siektes is jaarliks die grootste oorsaak van dood wêreldwyd. Behalwe die bekende 
risikofaktore soos swak dieetinname, fisiese onaktiwiteit en rook, verskyn kroniese psigologiese stres 
as 'n belangrike veranderlike risikofaktor in die ontwikkeling van miokardiale infarksie. Die liggaam 
maak staat op twee fisiologiese meganismes om akute stressors teen te werk en homeostase te 
bewerkstellig of te handhaaf, naamlik die hipotalamus-pituïtêre-byniere-as en die outonome 
senuweestelsel. Alhoewel dit 'n gekoördineerde fisiologiese reaksie is wat homeostase handhaaf, kan 
kroniese aktivering van hierdie stelsel lei tot die ontwrigting van sellulêre en sistemiese prosesse wat 
moontlik kan lei tot die ontwikkeling van neurologiese of psigosomatiese siektes. Beide kroniese 
sielkundige stres en iskemie-reperfusiebesering word geassosieer met 'n sterk inflammatoriese reaksie 
en die induksie van oksidatiewe stres. Maak kroniese psigologiese stres die hart meer vatbaar vir skade 
na iskemie en reperfusie, en wat is die rol van oksidatiewe stres en inflammasie in stresverwante 
disfunksie van die hart? Hierdie vraag vorm die basis van hierdie oorsig. Na 'n omvattende oorsig het 
ons vasgestel dat kroniese stres die hart meer vatbaar maak vir skade na die induksie van iskemie-
herperfusie. Na die hersiening van die meganismes wat betrokke is by iskemie-reperfusie en kroniese 
stres, het ons die hipotese vasgestel dat kroniese stres-geïnduseerde inflammasie en oksidatiewe stres 







Cardiovascular disease remains the leading cause of death worldwide (WHO, 2016). Apart from known 
risk factors such as poor dietary intake, physical inactivity and smoking, chronic psychological stress 
is emerging as an important modifiable risk factor in the development of cardiovascular disease (Yusuf 
et al., 2004). Here the focus is on acute coronary syndrome that describes any condition associated with 
sudden reduced blood flow to the heart resulting in myocardial infarction (Sanchis-Gomar et al., 2016). 
The reduced blood flow itself is not the only mediator of damage as the restoration of blood flow 
(reperfusion) can also elicit detrimental effects (Yellon and Hausenloy, 2007). Although there are 
several mechanisms implicated in this process the induction of oxidative stress and inflammation were 
identified as key mediators (Eltzschig and Eckle, 2011; Kalogeris et al., 2014; Granger and Kvietys, 
2015). As chronic psychological stress is known to also induce oxidative stress and inflammation in the 
heart (Schiavone et al., 2013; Salim, 2014; Y. Z. Liu, Wang and Jiang, 2017; Maydych, 2019), two key 
questions arise: a) does chronic psychological stress render the heart more susceptible to ischemia and 
reperfusion damage, and b) what are the role(s) of oxidative stress and inflammation in stress-related 




Hans Selye who is known as the modern-day ‘’father of stress’’ defined this in 1974 as the body’s non-
specific response to any demand (Goldstein and Kopin, 2007) that can either be of an intrinsic or 
extrinsic nature (Nicolaides et al., 2015). Homeostasis is subsequently re-established by both 
physiological (nervous, endocrine and immune systems) and behavioral adaptive responses (Chrousos, 
2009; Yang et al., 2015). Selye proposed three general stages of coping with a stressor i.e. the initial 
“alarm reaction” or  “fight-or-flight” response, a stage of adaptation that is associated with habituation 
of the stressor, and finally a stage of exhaustion or death (Goldstein and Kopin, 2007). This definition 
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remained relatively constant with the central concept being that the body is able to react to an external 
and internal stressor(s) by aiming to cope with the additional demands. 
 
Psychological stress is a major global health problem that requires a suitable response to help attenuate 
its overall impact on health and well-being. Here especially developing nations are hardest hit as shown 
by a survey (published in 2013) that listed the most stressed countries based on seven equally weighted 
parameters: homicide rates, income inequality, corruption perception, unemployment, urban air 
pollution, life expectancy and purchasing-power-parity basis (Bloomberg, 2013). Of note, the survey 
showed that South Africa was named the second most stressed country in the world, just behind Nigeria 




Figure 1.1: The most stressed-out countries – a global perspective (Abdullah., 2016). Scores are based 
on above mentioned parameters: countries with the least stressful measure for each parameter receive 0 
points, with a maximum of 100 points being available for countries with higher stress levels. Adapted from 




Keeping this alarming context in mind, it is important to consider the physiological responses mounted 
in order to attempt to restore homeostasis.  The human body relies on two physiological mechanisms to 
counter acute stressors and to achieve or maintain homeostasis (Chrousos and Gold, 1992; Golbidi, 
Frisbee and Laher, 2015), i.e. the hypothalamic-pituitary-adrenal (HPA)-axis and the autonomic 
nervous system (Nicolaides et al., 2015; Agorastos et al., 2018).  
 
2.1. The HPA-axis 
 
The first mechanism operating during a stressful situation is the activation of the HPA-axis (Tsigos and 
Chrousos, 2002; Agorastos et al., 2018) that involves release of corticotropin releasing factor (CRF) 
from the paraventricular nucleus (PVN) of the hypothalamus. CRF stimulates the production of 
proopiomelancortin, the precursor for adrenocorticotropic hormone (ACTH). Arginine vasopressin 
(AVP) works in synergy with CRF in stimulating ACTH secretion from the anterior pituitary (Juruena, 
2014; Gaffey et al., 2016). ACTH stimulates the release of glucocorticoids from the adrenal cortex, 
with cortisol the main glucocorticoid (in humans) that is produced in the zona fasciculata (Juruena, 
2014; Nicolaides et al., 2015).  
 
Cortisol elicits numerous downstream effects as part of the adaptive response triggered in response to 
stress. For example, it induces gluconeogenesis and counteracts insulin to thereby increase blood 
systemic glucose levels as part of the adaptive response to a stressful scenario(s) (Sherwood, 2010). 
Under basal conditions, cortisol acts as an anti-inflammatory agent (Straub and Cutolo, 2016). Cortisol 
mediates its negative feedback actions through association with two corticosteroid receptor subtypes: 
the glucocorticoid receptor (GR) that is located throughout the brain stem, amygdala, hippocampus and 
hypothalamus, and the mineralocorticoid receptor (MR) that is mainly located in the hippocampus 
(Juruena, 2014). Under normal conditions cortisol’s negative feedback is largely mediated by the MR 
while under stressed conditions it is facilitated by the less sensitive GR (Stephens et al., 2012; Juruena, 
















Figure 1.2: The negative feedback mechanisms of cortisol. ACTH: adrenocorticotropic hormone, AVP: 
arginine vasopressin, CRF: corticotropin releasing factor, GR: glucocorticoid receptor, MR: 
mineralocorticoid receptor.  
 
2.2. The autonomic nervous system 
 
The second important component operating during the stress response is the autonomic nervous system. 
Under conditions of stress, sympathetic nervous system activity can increase while there is a 
corresponding decrease in parasympathetic nervous system activity (Ziegler, 2012; Agorastos et al., 
2018). As discussed before, the hypothalamus secretes CRF and CRF-containing neurons then project 
into the locus coeruleus (Won and Kim, 2016). This in turn increases sympathetic nervous system 
activity through activation of α1-adrenergic receptors on preganglionic sympathetic neurons and 
attenuates parasympathetic nervous system activity through the activation of α2-adrenergic receptors 
on preganglionic parasympathetic neurons (Unnerstall, Kopajtic and Kuhar, 1984; Lewis and Coote, 
1990). The main neurotransmitters associated with the autonomic nervous system are norepinephrine, 
epinephrine and acetylcholine (Won and Kim, 2016). Norepinephrine and epinephrine are released 
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upon stimulation of the sympathetic nervous system, while acetylcholine is the main neurotransmitter 
of the parasympathetic nervous system (Won and Kim, 2016).  Both epinephrine and norepinephrine 
increase heart rate and the force of contraction. Epinephrine also dilates blood vessels in skeletal muscle 
to thereby decrease resistance to blood flow while norepinephrine increases blood flow to skeletal 
muscle. Both ultimately increase systemic blood pressure (Sherwood, 2010). 
 
Although the HPA-axis and autonomic nervous system function to physiologically adapt the body to 
cope with the acute internal or external stressors (Schneiderman, Ironson and Siegel, 2005), chronic 
activation of such mechanisms overrides homeostasis thereby leading to detrimental consequences. 
 
3. Stress-related morbidities 
 
Even though such an adaptive response is a coordinated physiological one that maintains homeostasis, 
chronic activation of this system can lead to the disruption of cellular and systemic processes resulting 
in dysfunction of both the nervous system and peripheral organ systems (Duric et al., 2016; Agorastos 
et al., 2018). Thus chronic stress can potentially lead to dysfunction of the systems that regulate the 
stress response, ultimately resulting in the development of neurological and psychosomatic diseases 
(Duric et al., 2016). It can also contribute to the onset of cardiovascular disease, the focus of this review. 
 
Major depressive disorder is increasingly attracting attention as one of the most common causes of 
disability and affecting close to 16% of the global population (Yang et al., 2015).  As a result there is 
an increased emphasis to delineate underlying mechanisms driving this pathological condition.  It is 
well known that chronic stress evokes neurological changes that are similar to those observed for major 
depression (Hill et al., 2012).  As a result, numerous chronic stress models are being used to investigate 
the underlying mechanisms contributing to the onset of depression with the aim to develop improved 




The World Health Organization (WHO) recently reported a staggering 17.9 million deaths annually 
worldwide resulting from cardiovascular disease, constituting 31% of total global mortality (WHO, 
2016). There are many factors that contribute to cardiovascular disease development. The most well 
known risk factors include physical inactivity, unhealthy diet (e.g. high sodium content) and smoking 
(WHO, 2016). These risk factors may ultimately manifest as high blood pressure, increased blood 
glucose levels and obesity. Apart from such  listed lifestyle-related risk factors, the INTERHEART 
study also listed chronic psychological stress as a modifiable risk factor for myocardial infarction 
(Yusuf et al., 2004).  
 
Acute coronary syndrome is a group of clinical symptoms that generally include ST-elevation 
myocardial ischemia (STEMI), non ST-elevation myocardial ischemia (NSTEMI), and unstable angina 
(Kumar and Cannon, 2009). A systematic review found that acute mental stress increased platelet 
activation and endothelial dysfunction in healthy individuals, rendering them more susceptible to acute 
coronary syndrome (Zupancic, 2009).  For example, a recent study found an increased incidence in 
myocardial infarction cases during World Cup soccer matches (1998, 2002, 2006, 2010), although it 
did not affect in-hospital mortality rates (Guilherme et al., 2013). Moreover, job strain - defined as high 
job demands and low decision latitude - is associated with increased hypertension incidence (Markovitz 
et al., 2004; Guimont et al., 2006). Here individuals with limited social support at the work place were 
at a relatively higher risk for developing hypertension (Guimont et al., 2006). Differences based on 
gender, age and socioeconomic status appear to be relatively minor, hence indicating that the association 
between work strain and the development of cardiovascular complications is strong (Kivimäki and 
Kawachi, 2015). 
 
Takotsubo cardiomyopathy - also known as ‘’broken heart syndrome’’ – is a stress-related complication 
that presents with ST-segment elevation, chest pain and increased creatine kinase and troponin levels 
(indicative of heart damage) (Szardien et al., 2013). These symptoms are known to appear after physical 
or emotional stress (Komamura, 2014). The prevalence of takotsubo cardiomyopathy among 
Stellenbosch University https://scholar.sun.ac.za
 7 
individuals with symptoms suggestive of acute coronary syndrome is ~0.7–2.5%, highlighting the 
similarity between acute coronary syndrome and takotsubo cardiomyopathy (Szardien et al., 2013).  
 
Throughout the literature there is evidence that psychological stress is associated with the onset of 
cardiovascular disease, specifically the induction of myocardial infarction (Ambrose and Singh, 2015; 
Kivimäki and Kawachi, 2015). However, the underlying mechanisms driving stress-related damage 
during myocardial ischemia and with reperfusion require further consideration.  
 
4. Stress-induced myocardial ischemia and reperfusion damage 
 
As discussed, myocardial infarction is a prominent feature of acute coronary syndrome. Myocardial 
infarction is the death of cardiomyocytes following an ischemic event in the myocardium (Davies, 1977; 
Norris, 1989; Hashmi and Al-Salam, 2015). How is stress linked to the onset of a myocardial infarction? 
An extensive systematic review of psychological stress-induced ischemia showed that psychological 
stress induces transient ischemia in humans (Strike and Steptoe, 2003). These responses were not due 
to severe emotional triggers, but rather behavioral challenges that could be encountered in everyday life 
(Strike and Steptoe, 2003). Others investigated the effects of mental stress at the time of acute 
myocardial infarction and found that patients experiencing moderate to high levels of stress are more 
prone to long-term adverse effects than patients experiencing lower levels (Arnold et al., 2012).  
 
The restoration of blood flow to the previously ischemic area is known to trigger further damage to the 
heart, a phenomenon referred to as ‘’lethal reperfusion injury’’ (Piper, Meuter and Schäfer, 2003; 
Eltzschig and Eckle, 2011; Vishwakarma et al., 2017). The question therefore arises whether chronic 
psychological stress impacts or contributes to lethal reperfusion injury. Of note, a repeated intermittent 
stress study done on rats showed an increase in infarct size following ischemia and reperfusion (Scheuer 
and Mifflin, 2017). Table 1.1 summarizes animal studies that investigated the links between chronic 
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stress and ischemia-reperfusion, with the common theme that chronic stress resulted in an increased 
infarct size following ischemia and reperfusion.  
 
Although the studies summarized in Table 1.1 clearly show a link between chronic stress and ischemia-
reperfusion damage, the question remains regarding the underlying mechanisms driving this process. 
The focus of the rest of the review will be on inflammation and oxidative stress, and the potential role 






Table 1.1: Animal studies assessing the effect of chronic stress on ischemia-reperfusion injury.  







Animal model Findings 
(Scheuer and 
Mifflin, 2017) 
Restrain stress (1-1.5 hours a day) 8 – 14 days In vivo 30’ ischemia 
180’ reperfusion 
Male Sprague Dawley 
rats 
­ infarct size 
2/6 developed severe 
arrhythmia 
Restraint stress (2 hours a day) 11 – 12 days In vivo 30’ ischemia 
180’ reperfusion 
Male Sprague Dawley 
rats 
­ infarct size 








Male Wistar rats ­ infarct size 
 
Psychological stress (Witness 
physical stress) 













Male Wistar Kyoto rats 
(5 weeks) 
- 




Female Wistar Kyoto 
rats (5 weeks) 
¯  Ventricular tachycardia 




Male SHR rats (5 
weeks) 
­ Ventricular tachycardia 
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Female SHR rats (5 
weeks) 
­ Ventricular tachycardia 
(Ravingerová 
et al., 2011) 




Male Wistar Kyoto  
rats (Adult) 
­ duration of ventricular 
tachycardia 
¯ LVDP recovery 




Male SHR rats (Adult) ­ LVDP recovery 






Predator exposure (Day 1 and 11) (1 
hour) 




Male Sprague Dawley 
rats (Adult) 
­ infarct size 
 
Social instability 
Predator exposure (Day 1 and 11) (1 
hour) 












5. Inflammation as a link between chronic stress and ischemia-reperfusion injury 
 
5.1. Chronic stress and inflammation 
 
5.1.1. HPA-axis and inflammation 
 
It is well known that activation of the HPA-axis under stressful situations leads to downstream 
production and secretion of cortisol from the adrenal glands (Tsigos and Chrousos, 2002; Stephens et 
al., 2012; Agorastos et al., 2018). Under normal conditions cortisol is a potent anti-inflammatory agent 
when bound to GR (Sorrells et al., 2009; Hannibal and Bishop, 2014).  However, under stressful 
conditions human plasma cortisol levels can increase ~10-fold above normal concentrations (Rogers et 
al., 2015).  GR resides in the cytoplasm in its inactive state where it associates with a complex of 
chaperone proteins including heat shock proteins (Juruena, 2014). After cortisol binds GR undergoes 
conformational changes and disassociates from this protein complex. GR then moves into the nucleus 
where it binds to DNA, i.e. targeting glucocorticoid response elements (GREs).  GREs can either induce 
a positive or negative feedback on the genes it is linked to (Juruena, 2014). For example, glucocorticoids 
exert its anti-inflammatory effects by suppressing the expression of nuclear factor kappa-light chain 
enhancer of B-cells (NFκB) and activator protein-1 (AP-1) through GR binding (Cruz-Topete and 
Cidlowski, 2014). Glucocorticoids are known to induce apoptosis of T-lymphocytes, basophils, 
neutrophils and eosinophils to ultimately reduce inflammation (Sorrells and Sapolsky, 2007). 
Additionally, in a model of lipopolysaccharide (LPS)-induced sepsis, glucocorticoids can regulate 
cytokine production through inhibiting p38 mitogen-activated-protein-kinases (MAPK) (Bhattacharyya 
et al., 2007; Busillo and Cidlowski, 2013). 
 
However, long-term cortisol secretion induces a pro-inflammatory state (Hannibal and Bishop, 2014).  
For example, rats with higher plasma corticosterone levels display increased prostaglandin E2 (PGE2) 
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accumulation (Pérez-Nievas et al., 2007). The potential mechanisms underlying this likely include GR 
resistance, impaired negative feedback and ultimately cortisol depletion (Hannibal and Bishop, 2014).   
Chronic and excessive cortisol secretion may also result in GR resistance which then prevents cortisol 
from binding to the GR. This results in the failure of GR to downregulate inflammation (Cohen et al., 
2012). The impaired binding to GR disrupts the negative feedback system, thus CRF and cortisol 
continue to be released (Hannibal and Bishop, 2014). Such spikes in cortisol secretion may also increase 
its affinity for MR, which when bound to cortisol, elicits pro-inflammatory effects (Hannibal and 
Bishop, 2014). The elevated inflammatory byproducts may then damage the GR to thereby worsen 
cortisol dysfunction (Yang, Ray and Matthews, 2012). The continuous cortisol secretion induced by the 
inability of the negative feedback to maintain its secretion ultimately results in adrenal fatigue. In 
support, animal studies showed decreased cortisol levels following two weeks of repeated restraint 
stress (Fries et al., 2005).  Thus, even though cortisol is regarded as an anti-inflammatory agent at basal 
levels, it is clear that chronic activation of the HPA-axis induces a pro-inflammatory state through 
cortisol’s inability to bind to GRs.   
 
5.1.2. The autonomic nervous system and inflammation 
 
As discussed, chronic activation of the HPA-axis induces a pro-inflammatory state. The autonomic 
nervous system also plays a vital role in the immune system. Here epinephrine and norepinephrine 
regulate the release of cytokines through α - and β-receptors on immune cells (Won and Kim, 2016). 
Studies show that norepinephrine increases tumor necrosis factor alpha (TNFa) production, while both 
epinephrine and norepinephrine stimulate the release of interleukin-6 (IL-6) (Bertini et al., 1993; 
Chrousos, 2006). By contrast, acetylcholine is known to inhibit TNFa production along with other pro-
inflammatory cytokines (IL-1 and IL-6) (Borovikova et al., 2000). These results support the fact that 
sympathetic nervous system activation induces a pro-inflammatory state, while parasympathetic 
nervous system activation attenuates it. Figure 1.3 summarizes the effect of the autonomic nervous 





Figure 1.3: Links between the autonomic nervous and immune systems. CRF: Corticotropin releasing 
factor, NE: norepinephrine, E: epinephrine, Ach: acetylcholine, SNS: sympathetic nervous system, PNS: 
parasympathetic nervous system, PVN: paraventricular nucleus. 
 
Activation of the HPA-axis and sympathetic nervous system are both involved in the stress response 
and studies showed that chronic activation of both systems can induce a pro-inflammatory state 
(Bertini et al., 1993; Chrousos, 2006; Smith and Vale, 2006). 
 
5.2. Ischemia-reperfusion and inflammation 
 
The previous section covered the role that inflammation plays during times of chronic stress. The next 
question to consider is what role inflammation plays during ischemia-reperfusion and whether this 
could potentially be exacerbated by chronic stress-induced inflammation? 
 
Inflammation constitutes a key component in the development of cardiovascular disease. IL-6 and C-
reactive protein (CRP) are two important biomarkers indicative of systemic inflammation and the onset 
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of atherosclerosis (Nadrowski et al., 2016; Y.-Z. Liu, Wang and Jiang, 2017). During ischemia-
reperfusion, the inflammatory signals are generated by cardiomyocytes and endothelial cells (Vinten-
Johansen, 2004). This sterile immune response involves activation of  the innate, adaptive immune 
response as well as the complement system (Eltzschig and Eckle, 2011) (Figure 1.4). 
 
 
Figure 1.4: The inflammatory response following ischemia-reperfusion. DAMP: damage associated 
molecular patterns, MAC: membrane attack complex, NFκB: nuclear factor kappa-light chain enhancer 
of B-cells, TLR: toll-like receptors.   
 
 
5.2.1. Innate immune response during ischemia-reperfusion 
 
The necrotic myocardial tissue (infarct zone) and damaged extracellular matrix release damage-
associated molecular patterns (DAMPs), that stimulate the complement cascade and also toll-like 
receptors (TLRs) resulting in the activation of NFκB and the subsequent stimulation of cytokines, 
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chemokines and cell-adhesion molecules (Fang et al., 2015). Complement fragments, cytokines and 
neutrophil activating protein are released from the myocardium at the site of ischemia-reperfusion and 
perform as activating or chemoattractant factors that can induce neutrophilic events (Vakeva et al., 
1998; Dörge et al., 2002). Although such an inflammatory response assists with wound healing, extreme 
inflammatory responses can cause left ventricular remodeling and heart failure (Fang et al., 2015).  The 
importance of inflammation in stress-related cardiac complications is supported by several studies. For 
example, TLR-4 deficient mice sustained smaller infarcts and decreased inflammation following acute 
myocardial infarction (Oyama et al., 2004; Timmers et al., 2008). Additionally, TLR-4 deletion reduced 
serum levels of TNFa, IL-6 and IL-1B (Kim et al., 2007), highlighting the importance of TLR-4 in 
mediating local and systemic inflammatory response during ischemia-reperfusion. Cell adhesion 
molecules, like intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-
1 (VCAM-1) are strong indicators of the activation of endothelial cells, leukocytes and platelets (Fang 
et al., 2015). Such circulating cell adhesion molecules, especially ICAM-1, are significantly related to 
future myocardial infarction or angina in healthy patients (Luc et al., 2003). 
 
mRNA profiling research showed that leukocytes (e.g. neutrophils and monocytes) are more active in 
the transcription of inflammatory genes in the blood of myocardial infarction patients (Wettinger et al., 
2005). Neutrophils play an important role in innate immunity and are known to infiltrate the infarcted 
area and mediate tissue damage by releasing reactive oxygen species and matrix-degrading enzymes 
(Vinten-Johansen, 2004; Fang et al., 2015). Previous studies confirmed that a high neutrophil count 
was strongly related to adverse clinical outcomes in patients with acute coronary syndrome (Núñez et 
al., 2008; Guasti et al., 2011). 
 
Monocytes are another leukocyte type that play an important role in atherosclerosis and acute coronary 
events, and are the most abundant immune cells in atherosclerotic plaques (Fang et al., 2015). 
Moreover, studies showed that monocytosis is associated with left ventricular dysfunction after acute 




5.2.2. Adaptive immune response during ischemia-reperfusion 
 
T-lymphocytes play a crucial role in the induction of the adaptive inflammatory response following 
ischemia-reperfusion injury (Eltzschig and Eckle, 2011), e.g. they can accumulate at the infarct zone 
24 hours after reperfusion (Schroeter et al., 1994).  In support, the inhibition of CD4+ T-lymphocyte 
accumulation and activation in the heart resulted in a decrease in infarct size following ischemia-
reperfusion in mice (Yang et al., in 2006). Furthermore, CD4 deficient mice were protected from 
ischemia-reperfusion injury in the liver (Zwacka et al., 1997), highlighting the crucial role of CD4 cells 
in the process of ischemia-reperfusion.  
 
5.2.3. Complement system during ischemia-reperfusion 
 
The complement system acts as a surveillance system that can differentiate between healthy tissue, 
cellular debris and foreign matter and elicit an according response (Eltzschig and Eckle, 2011). 
Excessive complement activation is detrimental, although a threshold in terms of activation is important 
in tissue regeneration (He et al., 2009). The necrosis induced by ischemia and reperfusion in endothelial 
cells results in the release of membrane constituents that are capable of triggering the complement 
system  (Zuidema, 2010). This includes the release of complement factor 3a (C3a), complement factor 
5a (C5a) and the cytolytic terminal membrane attack complex (MAC) (Arumugam et al., 2004). 
Complement factor 5 (C5) is cleaved by C5 convertase to yield C5a and MAC. C5a is known as one of 
the most inflammatory peptides (Hugli, 1986). MAC can also stimulate the release of reactive oxygen 
species (ROS) from monocytes thereby inducing further damage (Arumugam et al., 2004). The 
inhibition of C5 cleavage and hence the prevention of C5a and MAC formation can significantly reduce 




5.2.4. Pro-inflammatory cytokines 
 
Pro-inflammatory cytokines play an important role in the induction of the innate and adaptive immune 
responses. This happens through the stimulation of chemokines and adhesion molecules (Fang et al., 
2015). CRP is a well-known predictor of mortality in patients with acute coronary syndrome (Sheikh et 
al., 2012). Additionally, IL-6  also correlates with CRP levels as it is the main stimulus for CRP 
production in the liver (Dinarello, 2011). 
 
Even though the heart is under distress, other organs also play a role in the inflammatory response that 
contribute to the lethal reperfusion damage. Following myocardial infarction, monocytopoiesis in the 
spleen yields an increased monocyte production which could contribute to myocardial infarction 
through inducing leukocyte influx into atherosclerotic plaques (Leuschner et al., 2012; Fang et al., 
2015).  
 
As summarized in Figure 1.4, inflammation plays a major role in aggravating damage following 
reperfusion. The adaptive and innate immune responses both upregulate pro-inflammatory cytokine and 
chemokine production, while the complement system can further induce damage through MAC 
(Arumugam et al., 2004).  
 
To summarize this section, chronic psychological stress induces a pro-inflammatory state through 
activation of the HPA-axis and sympathetic nervous system (Bertini et al., 1993; Chrousos, 2006; 
Cohen et al., 2012). A pro-inflammatory state that could potentially aggravate the ischemia-reperfusion 






Figure 1.5: Inflammation as a potential mechanism whereby chronic psychological stress renders the 




6. Oxidative stress as a link between chronic stress and ischemia-reperfusion injury 
 
The second focus of this review is oxidative stress and the role it plays in chronic psychological stress 
and ischemia-reperfusion injury. 
 
6.1. Chronic stress and oxidative stress 
 
Psychological stress is associated with increased levels of oxidative stress (Aschbacher et al., 2013). 
For example, stress-mediated glucocorticoid-induced neurodegeneration may be caused by increased 
ROS production (Zafir and Banu, 2009).  Moreover, others showed increased serum levels of 8-
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hydroxy-2'-deoxyguanosine  - a known biomarker for oxidative damage - in patients with depression 
(Forlenza and Miller, 2006). 
 
Cortisol is a potential link between stress and oxidative stress (Aschbacher et al., 2013). In support, rats 
experiencing chronic stress or treated with corticosterone displayed decreased superoxide dismutase 
(SOD) and catalase activity (Zafir and Banu, 2009). Others found a strong correlation between the 
excretion of cortisol and oxidative markers in urine (Joergensen et al., 2011). Cortisol displays a strong 
inverted “U”-shaped relationship with mitochondrial function, an important role player in oxidative 
stress (Du et al., 2009). Brief high doses of cortisol improved mitochondrial function in cell culture 
models, while chronic high doses of cortisol dramatically decrease mitochondrial function and 
promoted cell death (Du et al., 2009). Another way whereby cortisol may potentially induce oxidative 
injury is by damaging intracellular constituents such as DNA and RNA (Gidron et al., 2006). In support, 
Gidron and colleagues reported a strong correlation between psychological factors (e.g. depression) and 
DNA-damage in humans (Gidron et al., 2006).   
 
As discussed, activation of the sympathetic nervous system by chronic stress leads to increased pro-
inflammatory cytokine production (Figure 1.3) (Won and Kim, 2016). These cytokines can enhance the 
activity of indoleamine 2,3-dioxygenase (IDO), which is the main enzyme responsible for converting 
tryptophan to kynurenine (Won and Kim, 2016). As indicated in Figure 1.6, downstream metabolites 
of this reaction (3-hydroxykynurenine and 3-hydroxyanthranilic) are known to induce oxidative damage 





Figure 1.6: Link between sympathetic nervous system-induced inflammation and oxidative stress. 
IDO: indoleamine 2,3-dioxygenase.  
 
 
6.2. Ischemia-reperfusion and oxidative stress 
 
The increase in reoxygenation to the previously ischemic tissue is accompanied by a burst of ROS 
which plays a significant role in myocardial reperfusion injury (Yellon and Hausenloy, 2007; González-
Montero et al., 2018). Examples of ROS include superoxide anion (O2-), hydrogen peroxide (H2O2) and 
peroxynitrate anion (ONOO-) (González-Montero et al., 2018). Oxidative stress forms part of the 
oxygen paradox where reoxygenation induces a degree of damage that exceeds that induced by the 
ischemia itself (Yellon and Hausenloy, 2007). The oxidative stress induced during reperfusion also 
decreases the bioavailability of nitric oxide, thus diminishing its cardioprotective effects (Yellon and 
Hausenloy, 2007). Xanthine oxidase (XO), uncoupled eNOS and NADPH oxidases (NOX) are the most 
important sources of ROS within the myocardium (Cadenas, 2018; González-Montero et al., 2018). 
Activation of NOX results in a one-electron reduction of oxygen to then generate the superoxide anion. 
NADPH oxidases are mainly present in activated neutrophils where they generate large amounts of 
superoxide (Brandes and Kreuzer, 2005; González-Montero et al., 2018). The damaging effects of NOX 
were emphasized by NOX-1 and NOX-2 knockout mice that displayed significantly attenuated 
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myocardial reperfusion injury compared to control mice (Braunersreuther et al., 2013).  However, they 
found no protective effects during the ischemic phase of the ex vivo protocol, suggesting the damage 
induced by NOX-1 and NOX-2 occurs during reperfusion (Braunersreuther et al., 2013).  
 
Xanthine oxidoreductase is crucial in the hydroxylation of xanthine to uric acid. This enzyme occurs in 
two interconvertible forms, xanthine dehydrogenase and XO, with the former being found 
predominantly in healthy tissue (Granger and Kvietys, 2015). During ischemia adenosine triphosphate 
(ATP) is catabolized to hypoxanthine. Additionally, xanthine dehydrogenase is converted to XO 
(Figure 1.7). Upon restoration of blood flow, there is an increased supply of oxygen availability, and 
oxygen reacting with hypoxanthine and XO to generate superoxide and hydrogen peroxide (Figure 1.7) 
(Granger and Kvietys, 2015). Despite there being evidence for the post-ischemic protective effects of 
XO inhibitors, other studies  failed to report any protection following inhibition of XO (Downey et al., 
1987; Metzger and Lauterburg, 1988). However, this is dependent on the baseline activity of XO, e.g. 
there is almost no XO expression in rabbit hearts (Downey et al., 1987) as is the case for human hearts 







Figure 1.7: The role of xanthine oxidase in the production of ROS during ischemia and reperfusion. 
ATP: adenosine triphosphate, ADP: adenosine diphosphate, AMP: adenosine monophosphate 
 
Superoxide dismutase catalyzes the dismutation of superoxide to hydrogen peroxide, with hydrogen 
peroxide thereafter reduced to water and oxygen (Dhalla et al., 2000). Activity and gene expression of 
MnSOD, catalase and glutathione peroxidase were significantly increased in hearts experiencing four 
cycles of ischemia and reperfusion, compared to those subjected to only one cycle (Das, Engelman and 
Kimura, 1993). Additionally, others found that overexpression of MnSOD rendered the heart more 
resistant to ischemia-reperfusion injury (Chen et al., 1998), therefore emphasizing the importance of 
anti-oxidants during ischemia and reperfusion.  
 
The role and expression of SOD, NOX and XO during ischemia-reperfusion emphasizes the importance 
of oxidative stress within the context of ischemia and reperfusion. How does this link with 
psychological stress? As mentioned above it is well known that oxidative stress is an important 
component in reperfusion injury (Yellon and Hausenloy, 2007; González-Montero et al., 2018) and is 
also a distinguishing feature during chronic psychological stress (Aschbacher et al., 2013; Won and 
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Kim, 2016). This could indicate that the pro-oxidative state induced by chronic psychological stress 





It is becoming evident that chronic psychological stress is a serious risk factor for the development of 
cardiovascular disease (Yusuf et al., 2004). It is clear that both ischemia-reperfusion injury and chronic 
stress are characterized by a robust inflammatory response together with the induction of oxidative 
stress (Figure 1.8).  In support, numerous studies found that chronic stress does indeed exacerbate 
ischemia-reperfusion injury (Table 1.1). However, the exact mechanisms linking stress and ischemia-
reperfusion injury require further investigation to ascertain whether it is actually stress-related 





Figure 1.8: Potential mechanisms involved in chronic psychological stress exacerbating ischemia-
reperfusion injury. Inflammation and oxidative stress both contribute to ischemia-reperfusion injury. 
Through chronic activation of the HPA-axis, cortisol’s anti-inflammatory properties are diminished. 
Additionally, persistent upregulation of the sympathetic nervous system and downregulation of the 
parasympathetic nervous system result in the production of pro-inflammatory cytokines. Together the pro-
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The stress response is a coordinated physiological response to external or internal stressors that aims to 
ultimately reestablish homeostasis. However, chronic activation of this system can lead to the disruption 
of cellular and systemic processes that can result in the development of neurological or psychosomatic 
diseases. Of note, psychological stress is recognized as a modifiable risk factor in the development of 
myocardial infarction, although underlying mechanisms driving this process remain unclear. This study 
therefore aimed to establish a model of chronic stress to determine whether it renders the heart more 
susceptible to damage following ischemia-reperfusion. Male Wistar rats were divided equally into a 
control and stress group (n = 12). Rats in the stress group were housed individually while control rats 
were housed two per cage. The stress group were subjected to the unpredictable chronic mild stress 
model, i.e. exposed to one random stressor six days a week over an eight-week period. At the end of 
this period, rat hearts were excised and employed for ex vivo heart perfusions while spleen tissue and 
plasma were used for oxidative stress and inflammatory tests, respectively. Our data reveal that 
circulating adrenocorticotropic hormone levels were lower within the stress group versus controls (p < 
0.05), while corticosterone concentrations remained unchanged.  Various markers for oxidative stress 
and inflammations showed no significant differences between the experimental groups. Following 
ischemia-reperfusion, the stress group displayed an increased infarct size compared to the control group 
(p < 0.05). These data show that the stress group experienced a degree of chronic stress that potentially 





Die stress reaksie is ‘n gekoordineerde fisiologiese reaksie op interne en eksterne stressors, met die eind 
doel om homestase te herstel. Alhoewel, kroniese aktivering van die sisteem kan lei tot die ontwrigting 
van sellulere en sistemiese prosesse wat kan lei tot die ontwikkeling van neurologiese of psigosomatiese 
siektes. Opmerklik word sielkundige stres erken as 'n veranderlike risikofaktor in die ontwikkeling van 
miokardiale infarksie, alhoewel die meganisme wat betrokke is nie duidelik is nie. Miokardiale infarksie 
is skade aan die hart as gevolg van ‘n vermindering van bloedvloei na miokardiale weefsel. Alhoewel, 
dit is egter bekend dat herstel van die bloedvloei self verdere skade aan die miokardium aandoen. Dit 
staan bekend as dodelike reperfusiebesering. Kroniese stress en iskemie-reperfusiebesering is beide 
geassosieer met 'n prominante inflammatoriese reaksie en die induksie van oksidatiewe stres. Die doel 
van hierdie studie was om 'n model van kroniese stres op te stel om te bepaal of kroniese stres die hart 
meer vatbaar maak vir skade na iskemie-reperfusie. Mannetjie Wistar-rotte is eweredig in 'n 
kontrolegroep en stresgroep verdeel (n = 12). Rotte in die stresgroep is afsonderlik gehuisves, terwyl 
kontrolerotte twee per hok gehuisves was. Die stresgroep is blootgestel aan die onvoorspelbare kroniese 
ligte stress model. Hulle is ses dae per week vir agt weke aan een willekeurige stressor blootgestel. 
Nadat rotte geëuthaniseer is, is die harte uitgesny en vir ex vivo hartvperfusies gebruik, terwyl 
miltweefsel en plasma vir biochemiese ontledings gebruik is. Miltweefsel is gebruik vir oksidatiewe 
stress ontledings, terwyl plasma gebruik was inflammatoriese en stresverwante merkers. 
Adrenokortikotropiese hormoon was laer in die stres groep (p < 0.05), terwyl corticosteron onveranderd 
gebly het. Oksidatiewe stress en inflammatoriese toetse het geen beduidende verskille tussen groepe 
getoon nie. Na iskemie-reperfusie het die stres groep ‘n groter infark gehad as die kontrole groep (p < 
0.05). Ter afsluiting, daar was tekens dat die stress groep wel ‘n graad van kroniese stress ervaar het. 
Ons resultate dui dat kroniese stress die hart meer vatbaar maak vir skade na iskemia-reperfusie. 
Alhoewel, die meganisme verantwoordelik vir die skade moet meer ondersoek word, aangesien 







Hans Selye who is known as the modern-day ‘’father of stress’’ defined stress as the body’s non-specific 
response to any demand (Goldstein and Kopin, 2007) that can either be of an intrinsic or extrinsic nature 
(Nicolaides et al., 2015). The body relies on two mechanisms to try and cope with a stressor: i) the 
HPA-axis and ii) the autonomic nervous system (Stratakis and Chrousos, 1995; Nicolaides et al., 2015; 
Agorastos et al., 2018). Activation of the HPA-axis ultimately results in secretion of cortisol (or 
corticosterone in rodents) the main glucocorticoid involved in the stress response (Nicolaides et al., 
2015; de Kloet et al., 2016). When cortisol levels increase, it elicits a negative feedback action through 
binding to GR and MR (Juruena, 2014) to help control circulating cortisol levels and maintaining 
homeostasis. When bound to the GR, cortisol also elicits anti-inflammatory effects through suppressing 
the expression of NFκB within the nucleus (Cruz-Topete and Cidlowski, 2014).  
 
Even though such an adaptive response is a coordinated physiological one that maintains homeostasis, 
chronic activation of this system can lead to the disruption of cellular and systemic processes resulting 
in dysfunction of both the nervous system and peripheral organ systems (Duric et al., 2016; Agorastos 
et al., 2018). Chronic activation of the HPA-axis is known to lead to GR resistance, impaired negative 
feedback and ultimately cortisol depletion (Hannibal and Bishop, 2014). With GR resistance, cortisol 
fails to bind to the GR and ultimately its anti-inflammatory effects and negative feedback actions are 
diminished (Cohen et al., 2012). Moreover, chronic stress has been linked with increased levels of 
oxidative stress (Aschbacher et al., 2013).  Thus chronic stress leads to the dysfunction of the systems 
that regulate the stress response, ultimately resulting in the development of neurological and 
psychosomatic diseases (Duric et al., 2016). Of note, psychological stress has been identified as a 




Myocardial infarction occurs as a result of decreased myocardial blood supply (Hoffman et al., 2004; 
Lu et al., 2015). However, restoring blood flow to the previously ischemic area can itself be a double 
edged sword, i.e. lethal reperfusion injury can exacerbate tissue damage and death following 
reoxygenation of the myocardium (Vinten-Johansen, 2004; González-Montero et al., 2018). As a robust 
inflammatory response and the induction of oxidative stress are key factors that mediate ischemia-
reperfusion injury (Vinten-Johansen, 2004; Kalogeris et al., 2014; González-Montero et al., 2018),  any 
risk factor that enhances the inflammatory or oxidative stress response (e.g. chronic psychological 
stress) could potentially exacerbate reperfusion injury. However, despite such implied links, the 
mechanisms driving stress-related myocardial injury in the setting of ischemia-reperfusion remain 
relatively poorly understood.   
 
The aims of this study were therefore to establish a rat model of chronic stress to evaluate inflammatory 
and oxidative stress markers, and to ultimately assess the effects of chronic stress on ex vivo ischemia-
reperfusion. Here we hypothesized that rats experiencing chronic stress will develop a pro-
inflammatory and pro-oxidative phenotype thereby rendering the heart more susceptible to damage 











Ethical approval was received prior to the start of this study from the animal ethics committee of the 
Stellenbosch University (South Africa) (ACU-2018-6311) (Appendix A). The animals used in this 
study were treated in accordance with the Guidelines for the Care and Use of Laboratory Animals of 
the National Academy of Science (NIH publication No. 85-23, revised 1996). Eight-week-old male 
Wistar rats (200- 250g) were divided into three groups; control (n = 12), stress (n = 12) and negative 
control (n = 8). The stress rats were housed individually, while the control group were housed two per 
cage. This is due to social isolation potentially acting as a stressor to the control group and interfering 
with the validity of the study. The two groups were also housed in different rooms. Negative control 
rats were not handled at all and were only used for perfusion and biochemical analyses. All rats were 
subjected to a normal light-dark cycle (i.e. lights on from 9 am to 9 pm). Rats had access to ad libitum 
food and water. Room temperature was maintained at 22°C ± 1°C.  The animals had one week to 
acclimatize to the new environment before the start of the study. 
 
2.2. Unpredictable chronic mild stress (UCMS) model  
 
The unpredictable chronic mild stress (UCMS) model was used for the duration of the study (Frisbee 
et al., 2015). The stressed rats were subjected to one random mild stressor during the light phase six 
days a week (Figure 2.1). These stressors ranged from four to eight hours, depending on the stressor 
and included no bedding, damp bedding, predator smells and a tilted cage. A full description of the 
stressors is provided in Table 2.1. Stressors were randomized each week to minimize habituation and 
maintain its unpredictability. On the seventh day of the week body weight and food consumption were 
measured (Figure 2.1). Food pellets were weighed at the start and end of each week to determine their 
weekly food consumption. The animals were subjected to a blood draw during the seventh week – to 
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be discussed later. After eight weeks, the rats were euthanized, and blood and tissues were collected, 
snap frozen and stored at -80°C for further analyses (Figure 2.2).  
 




Figure 2.1: Weekly protocol. An example of  a typical week for the stress group.   
 
Stressor Description Duration (hours) 
No bedding All bedding is removed and rats are placed into empty cages. 4 
Damp bedding Water is added to bedding. Pooling of water was avoided. 8 
Cage tilt Cages are tilted at an angle of ~40°. Bedding is also removed. 8 
Predator Concentrated predator urine (The Pee Mart, Vassalboro ME) 
is sprayed on the bedding of each cage. 
4 
Social stress Rats are placed in the cage of another rat.  4 




Figure 2.2: Experimental outline. Summary of the general experimental protocol. Blood draw took 
place during the 7th week of the protocol. 
 
2.3. Pilot study 
 
A pilot study was also conducted before the current study in order to establish the UCMS rat model in 
our laboratory. The aim was to confirm whether the rats developed a phenotype of chronic stress. This 
was a joint study that was completed by Lukas Olivier and Lucien Sher at Stellenbosch University. 
Here the data revealed that the stressors and experimental protocols adopted were not sufficient to 
induce adequate stress in the animals. All results obtained during pilot study added to supplementary 
data sheet (Appendix E). These results were, however, still useful as it allowed us to make alterations 
to our protocol to ensure the success of the current study (Table 2.2). Analyses included markers of 










Table 2.2: Changes made to the UCMS protocol following the pilot study. 
 
2.4. Blood collection 
 
Rats were anesthetized using 5% isoflurane gas (Piramel, Bethlehem PA) exactly one week before the 
end of the eight week protocol. Approximately 1 mL of blood was drawn from the right carotid artery. 
The blood was immediately transferred into ethylenediaminetetraacetic acid (EDTA) vacutainers (BD, 
Franklin Lakes NJ). The samples were centrifuged at 1, 000 x g for 15 minutes at 4°C (Boeco M240, 
Hamburg, Germany). Supernatant was transferred into a microfuge tube, snap frozen in liquid nitrogen 
and stored at -80°C for later analyses. 
 
2.5. Euthanasia and tissue/blood collection 
 
After the eight-week protocol, rats were injected with an overdose of sodium pentobarbital. The hearts 
were excised and used for ex vivo heart perfusions. Pooling blood in the chest cavity was collected using 
a 5 mL syringe and transferred to an EDTA tube. The EDTA tubes were subjected to centrifugation for 
15 minutes at 1, 000 x g and 4°C. Plasma supernatant was stored in microfuge tubes and frozen at -
Pilot study Current study 
Stressors during dark phase. Stressors during light phase. 
Control rats were housed individually. Control rats were housed 2 per cage. 
Control and stress rats were housed in same 
room. 
Control and stress rats were housed in separate 
rooms. 
Cage tilt, damp bedding and light/dark stressors 
lasted 4 hours each. 
Cage tilt, damp bedding and light/dark stressors 
increased to 8 hours. 
Cat sand and cat hair were used for predator 
stressor. 




80°C. The brain, liver, kidneys, adrenals, pancreas, spleen and gonads were all collected in similar tubes 
and snap frozen in liquid nitrogen and then stored at -80°C for future analyses. 
 
2.6. Ex vivo heart perfusions 
 
Hearts were perfused retrogradely (Langendorff method) at a constant pressure (100cm H2O). The heart 
was switched between Langendorff and working heart mode to assess functional capacity as well as 
induce ischemia and reperfusion (refer to Figure 2.3 for perfusion protocol) (Lochner, Genade and 
Moolman, 2003). Krebs-Henseleit bicarbonate buffer (119 mM NaCl, 25 mM NaHCO3, 4.75 mM KCl, 
1.2 mM KH2SO4, 0.6 mM MgSO4.7H2O, 0.6 mM Na2SO4, 1.25 mM CaCl2.H2O, D–(+)-glucose) 
(Appendix D) was used as the perfusate and was oxygenated and kept at a pH of 7.4 by gassing (95% 
O2. 5% CO2). The perfusion setup was coated with a water jacket to maintain an internal temperature 
of ~36.8°C. 
 
To induce regional ischemia, the left anterior descending (LAD) coronary artery was tied off using a 
silk suture and the temperature of the heart was monitored and kept at ~ 36.8 °C.  After ischemia the 
knot was undone, and the heart was reperfused for 10 minutes and given the chance to recover. 
Functional recovery was assessed by comparing function prior to and after ischemia and was expressed 
as a percentage (Appendix D).  
 
 





2.6.1. Infarct size determination 
 
After the perfusion protocol the suture was tightened at the same spot and a 0.5% Evans Blue solution 
was slowly injected through the aorta (Lochner, Genade and Moolman, 2003). The heart was frozen 
overnight at -10°C before being sectioned into five equally thick slices (~ 2mm). The heart was cut 
from the apex towards the knot (transverse). The slices were incubated in 1% triphenyltetrazolium 
chloride (TTC) in phosphate buffer (pH 7.4) for ~ 7 minutes. The slices were then fixed in a 10% 
formaldehyde solution for approximately one hour to enhance the contrast between the viable tissue 
and the infarcted area. The viable tissue (V), area at risk (AR) and infarct zone (I) was sketched onto 
transparent paper (Figure 2.4). ImageJ (National Institutes of Health, USA) was used to determine the 
area of these sections and to calculate the infarct size. Infarct size and area at risk were calculated as 
follows: 
 
!"#$%&'	)*+, = 	 !(/0 + !) 	× 	100																					/%,$	$'	%*)6	)*+, = 	
(/0 + !)




       
Figure 2.4: Example of how viable tissue (V), area at risk (AR) and infarct zone (I) was represented 








2.7. Plasma analyses 
 
ELISA kits for ACTH (E-EL-R0048), corticosterone (E-EL-R0269) and hs-CRP (E-EL-R0506) were 
acquired from Elabscience (Elabscience Biotechnology Inc, Houston TX). The ACTH and 
corticosterone kits used the competitive-ELISA principle, while the hs-CRP kit used the sandwich-
ELISA principle (Appendix B). Plasma samples that were collected after the blood draw during the 7th 
week were used for the ACTH and corticosterone ELISA kits. Plasma samples collected following 
euthanasia were used for the hs-CRP ELISA. Plates were read at a wavelength of 490nm on the EZ 
Read 400 Microplate reader (Biochrom, Holliston MA) and results were calculated from the standard 
curve. 
 
2.8. Tissue analyses 
 
As there were no heart tissues available for biochemical analyses after perfusions, we decided to focus 
on the spleen. The spleen is an integral part of the lymphatic system and plays a role in the production 
of lymphocytes (Mitchell, 1973). Chronic inflammation can consequently induce oxidative stress and 
attenuate anti-oxidant capacity (Khansari, Shakiba and Mahmoudi, 2009). Spleen samples were 
prepared in a 1x PBS solution (Appendix C) at a 1:10 ratio for SOD and thiobarbituric acid reactive 
substances (TBARS). The TBARS assay measures natural byproducts of lipid peroxidation, like 
malondialdehyde (MDA). TBARS was read at a wavelength of 532 nm in the Multiskan® Spectrum 
microplate spectrophotometer (Thermo Fisher Scientific, Massachusetts, USA) (Appendix C). The 
SOD assay measures the auto-oxidation of 6-hydroxydopamine (6-HD) and it’s activity was assessed 
over a period of five minutes on the Multiskan® Spectrum microplate spectrophotometer (Thermo 
Fisher Scientific, Massachusetts, USA) (Appendix C). Figure 2.5 summarizes all the analyses during 




Figure 2.5: Experimental procedure. Schematic illustration and summary of the experimental procedure 
that was followed after sample collection. ACTH: adrenocorticotropic hormone, hs-CRP: high sensitivity C-
reactive protein, SOD: superoxide dismutase, TBARS: thiobarbituric acid reactive substances, UCMS: 
unpredictable chronic mild stress. 
 
2.9. Statistical analyses 
 
Graphpad Prism 8 (Graphpad Software Inc, San Diego, CA) was used for all statistical analyses and 
data was analyzed with the assistance of Prof. Martin Kidd, a statistician based at the Centre for 
Statistical Consultation at Stellenbosch University. All data was tested for normality and the presence 
of any outliers. The Students t-test was used to compare the control and stress group. One-way ANOVA 
was used to compare control, stress and negative control group, with a Bonferroni post hoc test. 







As this was part of a joint study and plasma samples were shared, corticosterone and ACTH tests were 
done with a sample size of (n = 6). However, in combining the results with data acquired by Lucien 
Sher, we achieved a joint sample size of (n = 12). Body weight and food consumption data are also 
shared and accredited to both myself (Lukas Olivier) and Lucien Sher. All heart and spleen tissues were 
used by myself for ex vivo heart perfusions and oxidative stress analyses respectively. 
 
3.1. Body weight and food consumption 
 
Body weight was taken once a week for the duration of the eight week study. Here the control group 
weighed significantly more than the stress group at the start of the experiment (p < 0.0001) (Figure 
3.1A). When the data are expressed as percentage growth this shows that the stress group gained 
significantly more weight throughout the eight week protocol (Figure 3.1B). Although the stress group 
gained more weight over the 8-week duration of the experiment (p < 0.0001) (Figure 3.1B), there was 
still a weight difference of 9.63 ± 2.81% at the end of the experiment, compared to the 25.93 ± 3.7% 
seen during week 1. During the first week the control rats consumed significantly more food than the 
stress group (p < 0.05), however the stress group consumed more food during the fifth (p < 0.001), sixth 
(p < 0.001) and eighth (p < 0.05) weeks (Figure 3.2). As the variation in rat weights at the end of the 
experiment may impact on our data analyses, correlation tests were completed (in collaboration with 
Prof. Martin Kidd of the Centre for Statistical Consultation at Stellenbosch University) to assess the 
impact of the body weight difference on other analyses performed. Such an analysis revealed that the 
difference in body weight was not a confounding factor and did not have any effect on any of our 











Figure 3.1: Body weight (A) and percentage growth (B) results over the eight week period (Sher and 
Olivier, unpublished data). Data presented as mean ± SEM; statistical analyses: repeated measures, two-
way ANOVA, Bonferroni post hoc; *p<0.05, ****p<0.0001; n = 12. 
 
 
Figure 3.2: Food consumption over the eight week protocol (Sher and Olivier, unpublished data). Data 
presented as mean ± SEM; statistical analyses: repeated measures, two-way ANOVA, Bonferroni post hoc; 
*p<0.05, ***p<0.001; n = 12. 
 
 
3.2. Ex vivo heart perfusions 
 
3.2.1. Functional parameters 
 
Throughout the 125-minute perfusion protocol heart rate and coronary flow were assessed at various 
time points. Our findings show that there were no statistically significant differences between the groups 
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(Table 3.1). As expected our results confirm that the coronary flow was markedly attenuated during 
ischemia (p < 0.0001). 
 
 
Table 3.1: Heart rate and coronary flow before and after ischemia was induced (during Langendorff). 
Data presented as mean ± SEM; statistical analyses: one-way ANOVA, Bonferroni post hoc; * p < 0.0001 
for B vs. A & C. n = 10-11. BPM – beats per minute. 
 
 
3.2.2. Functional recovery 
 
Functional recovery indicates how well the heart’s functionality recovered following ischemia and 
reperfusion. The results are expressed as a percentage recovery of functionality following ischemia-
reperfusion. Our data show no significant differences for functional recovery between the groups 
(Figure 3.3).  
 
 













Control 271.7 ± 12.5 9.4 ± 0.5 5.2 ± 0.4 * 274.9 ± 7.2 8.6 ± 0.4 




Figure 3.3: Percentage recovery of functional ability after ischemia and reperfusion. Data displayed as 
mean ± SEM; statistical analyses: unpaired t-test; n = 10-11. 
 
3.2.3. Infarct size and area at risk 
 
The stress group displayed an increased infarct size compared to the control group (p < 0.05) (Figure 
3.4A).  There were also no significant differences for the area at risk (Figure 3.4B), confirming that the 






















Figure 3.4:  Size of infarct (A) and area at risk (B) displayed as a percentage. Data displayed as mean ± 
SEM; statistical analyses: unpaired t-test, Bonferroni post hoc; *p<0.05; n = 12. 
 
3.3. Biochemical analyses 
 
3.3.1. Stress related markers 
 
Plasma corticosterone showed no differences between groups (Figure 3.5A). A similar pattern was 
observed with the combined data (for the larger study, in collaboration with Lucien Sher) (Figure 3.5B). 
However, our findings show lower ACTH levels in the stress group (Figure 3.6A) and this became 




















Figure 3.5: Plasma corticosterone results of this study (A) (n = 6) and plasma corticosterone of joint 
study (Sher and Olivier, unpublished data) (B) (n = 12). Data displayed as mean ± SEM; statistical 












Figure 3.6: Plasma ACTH results of this study (A) (n = 6) and plasma ACTH of joint study (Sher and 
Olivier, unpublished data) (B) (n =12). Data presented as mean ± SEM; statistical analyses: unpaired t-




3.3.2. Oxidative stress 
 
As no heart tissue was available for biochemical analyses, spleen tissue was used to determine the 
oxidative stress activity following the stress protocol. However, SOD activity and MDA concentration 












Figure 3.7: Oxidative stress analyses. Malondialdehyde concentration (A) and superoxide dismutase 
activity (B) in spleen tissue. Data displayed as mean ± SEM; statistical analyses: unpaired t-test; n = 12. 
SOD: superoxide dismutase 
 
3.3.3. Systemic inflammation 
 
CRP was measured within the plasma as it’s a good marker for indicating any cardiovascular 
complications or stress related complications (Sheikh et al., 2012). However, plasma analyses of hs-





Figure 3.8: Plasma concentration of hs-CRP . Data displayed as mean ± SEM; statistical analyses: 








As discussed, chronic stress is increasingly being recognized as a risk factor in the development of 
cardiovascular disease (Yusuf et al., 2004).  As the underlying mechanisms driving this process remain 
unclear, this study aimed to establish a model of chronic stress with the aim to assess its impact in 
response to ex vivo ischemia-reperfusion. The main findings of this study include: i) the establishment 
of the UCMS model, and ii) increased infarct sizes in the stress group following ischemia-reperfusion.  
 
4.1. The UCMS model 
 
The UCMS model was chosen for this project as it is one of the most translationally relevant chronic 
stress models for studying the pathology of depression (Frisbee et al., 2015). The UCMS model 
provides the opportunity for greater insight into molecular, genetic and epigenetic factors that may 
contribute to the onset of depression, as well as identifying potential therapeutic targets (Frisbee et al., 
2015). This model is widely used as it reproduces clinical symptoms of depression observed in humans 
e.g. anhedonia and learned helplessness (Frisbee et al., 2015). Studies do indicate that unpredictable 
forms of stressors are more likely to induce depressive symptoms than restraint stress (Zhu et al., 2014). 
Furthermore, such outcomes can be reversed by the use of anti-depressants, emphasizing the similarity 
between human depressive symptoms and the UCMS model (Frisbee et al., 2015).  
 
The use of preclinical animal models offers a great translational tool in studying stress-related illnesses 
(e.g. depression) and potential links to comorbidities. Of note, depression is increasingly present in 
patients with coronary heart disease and is independently connected to cardiovascular morbidity and 
mortality (Lichtman et al., 2009). Apart from contributing to coronary heart diseases risk (Carney and 
Freedland, 2017), depression may render the heart resistant to cardioprotective interventions (Headrick 




Behavioral and molecular tests (e.g. corticosterone and ACTH) are useful tools whereby models of 
chronic stress can be validated. As we did not perform any behavioral tests (due to excessive workload), 
we relied solely on molecular analyses to validate the UCMS model. These results will be thoroughly 
discussed. 
 
In addition to anhedonia, models of chronic stress are known to reduce the rate of weight gain in rodents 
(Willner, 2017). For the current study we found contrasting results as the control group weighed 
significantly more than the stress group (Figure 3.1A). During the first week of the experiment the 
control group consumed significantly more food than the stress group, while the stress group consumed 
significantly more food during the fifth, sixth and eighth weeks. This correlates well with the percentage 
growth as the stress group gained significantly more weight over the eight week period (Figure 3.1B). 
However, after completion of the experiment we discovered that the rats were age-matched at the start 
of the experiment but regrettably not weight-matched. This unfortunate oversight was only detected at 
the end of the experiment and meant we had to complete additional statistical analyses to determine 
whether body weight was indeed a confounding factor in our study. Here detailed correlation tests were 
completed with the assistance of Prof. Martin Kidd, a statistician based at the Centre for Statistical 
Consultation at University of Stellenbosch. Such analyses revealed that the only significant body weight 
effect that we identified was a correlation with the infarct size data – to be discussed later. 
 
Following our eight week protocol corticosterone levels remained unchanged between groups. 
Contrasting results are found in other studies also employing the UCMS model as they found 
significantly higher corticosterone levels in the C57BL/6J inbred mouse strain (Van Boxelaere et al., 
2017) and Wistar Kyoto rats (Bernatova et al., 2018). Here the latter study used decapitation as the 
method of termination following carbon dioxide anesthesia. This method could potentially minimize 





Surprisingly, circulating ACTH levels were significantly lower in the stress group.  As discussed, our 
initial thoughts were that during the anesthesia process the control group experienced a degree of stress 
that ultimately enhanced their stress response, thus expected to increase ACTH and corticosterone 
levels. However, this was not the case when assessing the ACTH data.  Therefore, we propose that a 
method reflecting corticosterone levels over months is needed as it should provide a better reflection of 
underlying physiology and pathophysiology. Here the measurement of corticosterone in hair samples 
is increasingly becoming a suitable method for determining corticosterone concentrations over extended 
periods of time (Sauvé et al., 2007; Golbidi, Frisbee and Laher, 2015). In support, Kalra and colleagues 
found that maternal hair cortisol levels correlated positively and significantly with measures of 
perceived stress (Kalra et al., 2007). This would eliminate any chance of anesthesia-mediated stress 
interfering with our analyses. Thus, one possibility is that our corticosterone and ACTH findings may 
– in part – be explained by the choice of anesthetics for our study.  
 
Another possibility also exists, i.e. reported GR resistance following chronic stress. During GR 
resistance corticosterone fails to bind to the GR, thus diminishing its anti-inflammatory effects and 
negative feedback functions (Cohen et al., 2012; Yang, Ray and Matthews, 2012). We propose that 
such a negative feedback loop may be operational in our model, although additional studies are required 
to confirm this.  This then begs the question why cortisol is similar, but ACTH significantly reduced in 
the stress group. In the absence of GR resistance, corticosterone is still able to elicit its negative 
feedback function. Thus, ACTH levels could be reduced in the stress group to compensate for the 
chronically elevated corticosterone levels and ultimately decrease adrenal corticosterone secretions. 
This could indicate that despite the stress group experiencing a certain degree of stress, the chronic 
stress protocol here employed was not severe enough to induce GR resistance.  
  
Our data did not reveal any significant differences for plasma CRP concentrations between the control 
and stress groups.  A previous study on rabbits reported elevated plasma levels of CRP when using the 
UCMS model (Lu et al., 2012). The lack of differences in CRP levels supports the notion that our eight-
week UCMS protocol was not severe enough to elicit changes in GR expression as other studies show 
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that GR resistance is often accompanied by a pro-inflammatory state (Sorrells and Sapolsky, 2007; 
Hannibal and Bishop, 2014; Headrick et al., 2017). As discussed, corticosterone is prevented from 
binding to GR in the cytoplasm in the case of GR resistance. Consequently, GR fails to translocate into 
the nucleus and bind to the GREs within the DNA (Padgett and Glaser, 2003; Barnes, 2015). 
Transcriptional activity of the downstream genes are subsequently altered (Sorrells and Sapolsky, 
2007), i.e. the inability of GR to bind to GREs results in the failure to downregulate the transcriptional 
activity of  NFκB and AP-1 and the anti-inflammatory properties of corticosterone are diminished 
(Sorrells and Sapolsky, 2007; Straub and Cutolo, 2016).  Thus we suggest that future studies should 
focus on NFκB as a driver of a pro-inflammatory milieu (Clark, 2007).  
 
As all hearts were used for ex vivo heart perfusions and infarct size determination there were no cardiac 
tissues available to assess oxidative stress. We therefore decided to do an assessment using spleen tissue 
as it is one of the largest secondary immune organs and plays an important role in disease development 
(e.g. myocardial infarction) (Swirski et al., 2009; Jiang et al., 2017).  Of note, enhanced ROS generation 
by immune cells can lead to a state of oxidative stress (Chatterjee, 2016).  However, there were no signs 
of lipid peroxidation or changes in SOD activity within the spleen tissue. By contrast, a study using a 
chronic social isolation stress model in rats found increased spleen MDA concentrations after 13 weeks  
(Gavrilović et al., 2018). This adds support to the concept that our UCMS model represents a moderate 
phenotype.  As there was no systemic inflammation in our model and as it is known to play a role in 
the induction of oxidative stress (Chatterjee, 2016), this could explain why there were no signs of lipid 
peroxidation or any changes in SOD activity in this case.  Of note, additional oxidative stress analyses 
were conducted on liver and brain tissue by other researchers in our group (Essop laboratory, 
unpublished data). These results reveal increased oxidative stress in both tissues thus supporting a 
moderate stress phenotype in our UCMS model. We can also speculate that the UCMS model might be 
simulating signs of post-traumatic stress disorder (PTSD) in the rats. Here the unchanged corticosterone 
levels support the fact that with PTSD there is lowered HPA-axis activity (Kolassa et al., 2007). 
Unresponsive HPA-axis also correlates well with our ACTH findings, although more studies are 
required to investigate such propositions. 
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4.2. Increased infarct size following ischemia-reperfusion 
 
There are paradoxical reports about the effects of stress on the cardiovascular system. For example, 
acute stress is known to decrease myocardial sensitivity to ischemia-reperfusion injury (Eisenmann, 
Rorabaugh and Zoladz, 2016), while others found that chronic stress exacerbates ischemia-reperfusion 
injury (Table 1.1). Results from the current study support the majority of these findings as the infarct 
size of the stress group was significantly increased following ischemia-reperfusion protocol. Although 
it is established that chronic stress exacerbates ischemia-reperfusion injury, the potential mechanisms 
contributing to this process still remain elusive. We therefore hypothesized that potential mechanisms 
involved is likely to be of a pro-inflammatory and pro-oxidative nature within the heart and/or impaired 
corticosterone catabolism.  
 
Cortisol is well-known to inhibit insulin and ultimately increase blood glucose levels (Al-sharefi, 2016). 
Chronic stress also induces insulin-resistance thereby contributing to a hyperglycemic state (Tsigos et 
al., 2000; Kyrou and Tsigos, 2007). Both hyperglycemia and insulin-resistance are known to impair 
infarct tolerance and cardioprotective signaling (Hausenloy et al., 2013). However, we found no 
significant differences in plasma corticosterone levels between groups. Interestingly, chronic stress 
induces long-term lowering of glucocorticoid catabolism (Yehuda and Seckl, 2011), suggesting that the 
actions of corticosterone in the stress group are prolonged compared to the control group despite plasma 
concentrations being similar. Thus, we propose that altered corticosterone catabolism could be a factor 
responsible for the aggravated injury. However, further studies are required to investigate this idea.  As 
increased inflammation and oxidative stress are indeed major contributors to ischemia-reperfusion 
injury within the heart (Zuidema, 2010; Eltzschig and Eckle, 2011; Kalogeris et al., 2014), it remains a 
possibility that chronic stress induced a pro-inflammatory and pro-oxidative state within the heart that 
aggravated the ischemia-reperfusion injury. Little is known about the mechanistic features of stress or 
depression aggravated infarction, with the majority of literature limited to expression of anti- and pro-
apoptotic proteins (Wang et al., 2013).  Hence more studies need to done to assess the molecular effects 
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of chronic stress on myocardial inflammation and oxidative stress prior to and after ischemia-
reperfusion in order to ascertain what exactly is causing the aggravated injury. 
 
As rats were not weight matched and the difference between groups were significant, correlation tests 
were completed to assess if there were any correlations between these results and body weight at the 
time of euthanasia.  As mentioned before, the only significant correlation identified was between infarct 
size and body weight.  Thus the possibility exists that infarct size was not significantly altered by our 
stress protocol, but instead being representative of body weight differences.  However, correlation does 
not always mean causation. As all the rats in the control group weighed significantly more than the 
stress group, it means that any other significant finding relating to the two experimental groups would 
indeed correlate either positively or negatively with body weight. Moreover, as infarct size was the only 
parameter that correlated with body weight, we speculate that the change in infarct size was not due to 
body weight but rather as a result of the chronic stress protocol.  However, further studies are required 
to conclusively prove this notion. 
 
Although infarct size results indicated promising results, there were no significant differences in 
functional recovery and other functional parameters between the groups following ischemia and 
reperfusion. The coronary flow was reduced significantly during ischemia (for both groups) as would 
be expected but increased again following reperfusion.  Of note, a decrease in infarct size is not always 
associated with improved functional recovery, thus indicating that increased infarct size is not 




As discussed, the fact the rats were not weight matched remains a limitation of this study.  During this 
taxing study we were unable to complete any behavioral tests due to sheer workload, making it difficult 
to fully establish whether the rats were sufficiently stressed after the eight week protocol. Blood 
pressure analyses were done at the start, middle and end of the study to serve as another method of 
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confirming the onset of stress. However, technical difficulties with the equipment meant that we could 
not use these data due to significant variability and inaccuracies. Of note, this method included 
restraining the rats in a small Perspex tube for the duration of the analysis and hence exposed our control 




Cardiovascular disease remains a major, global health problem contributing to ~ 31% of global yearly 
deaths (WHO, 2016).  Apart from well known risk factors, chronic psychological stress is increasingly 
associated with the onset of myocardial infarctions (Yusuf et al., 2004). Both chronic psychological 
stress and ischemia-reperfusion injury are associated with increased oxidative stress and inflammation. 
The aim of this study was to assess the pro-inflammatory and pro-oxidative effects of chronic stress, 
and whether it would render the heart more susceptible to ischemia-reperfusion injury. Following eight 
weeks of the UCMS protocol, the collective data suggest that the stress group did experience a degree 
of chronic stress together with increased infarct sizes compared to the control group. Even though there 
were no signs of oxidative stress or systemic inflammation, chronic stress still impaired the heart’s 
infarct tolerance and potentially interfered with cardioprotective mechanisms. This study highlights the 
complex interplay between the brain and the heart and the importance to better understand the brain-
heart axis. Such efforts should eventually help to lower the prevalence of cardiovascular-related 
complications that stem from chronic stress-related illnesses. 
 
5.1. Future recommendations  
 
For future studies it is important that behavioral tests be added (e.g. sucrose preference test, sucrose 
spray test) to better assess stress levels of stress in the model. This should assist in determining the 
efficacy of the protocol.  In addition, measuring corticosterone and ACTH levels at different time points 
may also provide greater insight regarding the nature of the UCMS model, while a different method of 
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measuring corticosterone levels (e.g. hair corticosterone) should provide a ‘snapshot’ of levels over the 
past few months. An important addition could be to increase the sample size to assess myocardial 
inflammation and oxidative stress prior to and after ischemia reperfusion. This should provide greater 
insights regarding underlying mechanisms at play in the heart following eight weeks of the UCMS 
model. Lastly, assessing metabolic markers such as circulating insulin and glucose levels may lead to 
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The following appendix includes the protocol followed for the following ELISAs: ACTH (E-EL-
R0048), corticosterone (E-EL-R0269) and hs-CRP (E-EL-R0506). ACTH and corticosterone kits 




• Standard working solution: After the standard was centrifuged at 1000 g for 60 seconds 
(Boeco M240, Hamburg, Germany), 1 mL of plasma sample and standard diluent was added to 
achieve the appropriate concentration for each kit. Seven additionally serial dilutions were 
made for the standard curve.  
 
• Biotinylated Detection Antibody (Ab) working solution: With the amount of desired wells 
in mind, a 1x solution was prepared with biotinylated detection Ab diluent (50 µL/well).  
 
• Horse radish peroxidase (HRP) conjugate working solution: With the amount of desired 
wells in mind, a 1x solution was prepared with HRP-conjugate diluent (100 µL/well). 
 
• Wash buffer: Add 30 mL of concentrated wash buffer to 720 mL of distilled water (dH2O). 
 
Assay Procedure (Competitive ELISA): ACTH (E-EL-R0048) and corticosterone (E-EL-R0269). 
 
It is important to note that for the competitive ELISA the 96-well plate supplied is coated with the 




1. 50 µL of standards and sample were added in duplicate in a 96-well plate. Immediately after, 
50 µL of Biotinylated Detection Ab working solution was added and the plate was incubated 
at 37°C for 45 minutes. As a result, the anti-bodies within the sample can compete with the 
biotinylated detection anti-bodies in binding to the antigen. 
2. 350 mL of wash buffer was added to wells and allowed to soak for 1 minute. This was repeated 
three times in total. This is to remove any unbound anti-bodies in the wells. 
3. 100 µL of HRP conjugate working solution was added to each well and the plate incubated 
at 37°C for another 30 minutes. HRP is the enzyme that binds to the biotinylated detection Ab. 
4. The plate was then washed 5 times as in step 2. This removes any unbound HRP.  
5. 90 µL of substrate reagent was added to each well, after which the plate was incubated at 
37°C for 15 minutes. The reaction between the HRP conjugate and the substrate reagent 
produce a clear blue color. Less blue color indicates more antibody sample bound to antigens, 
while the converse holds true.  
6. 50 µL of stop solution was added to each well immediately after and the plate was read at 450 




Assay Procedure (Sandwich ELISA): hs-CRP (E-EL-R0506). 
 
It is important to note that for the sandwich ELISA, the 96-well plate supplied is coated with an anti-
body designed to bind the antigen under investigation (CRP). 
 
1. 100 µL of standards and sample were added in duplicate in a 96-well plate and the plate was 
incubated at 37°C for 90 minutes. This allows the antigen of under investigation to bind to the 
anti-body coated wells. 
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2. Liquid was removed and 100 µL biotinylated detection Ab working solution was added to each 
well, after which the plate was incubated at 37°C for 60 minutes. The biotinylated detection anti-
body then binds to the antigen (creating an anti-body || antigen || anti-body “sandwich”). 
3. 350 mL of wash buffer was added to wells and allowed to soak for 1 minute. This was repeated 
three times in total. This removes any unbound anti-bodies and antigens. 
4. 100 µL of HRP conjugate working solution was added to each well and the plate was incubated 
at 37°C for another 30 minutes. The HRP conjugate bind to the biotinylated detection anti-body. 
5. The plate was then washed 5 times as in step 3.  
6. 90 µL of substrate reagent was added to each well, after which the plate was incubated at 37°C 
for 15 minutes. The reaction between the HRP conjugate and the substrate reagent produce a clear 
blue color. Unlike the competitive ELISA, the darker blue color indicates the presence of higher 
antigen levels in your sample. 
7. 50 µL of stop solution was added to each well immediately after and the plate was read at 450 



























The following appendix includes protocols for TBARS and SOD activity. 
 
TBARS: This assay measures natural bi-products of lipid peroxidation, like malondialdehyde (MDA) 





• 1x  Phosphate buffer saline (PBS):   
o 800 mL of dH2O + 8 g of NaCl + 0.2 g of KCl + 1.44 g of Na2HPO4 + 0.24 g of KH2PO4. 
o Adjust pH to 7.4 using HCl. 
o Top up to one liter using dH2O. 
• Ortho-phosphoric acid (0.2 M): 
o 684 µL orthophosphoric acid (14.62 M) + 40.5 mL H2O. 
• Butylated hydroxytoluene (BHT) working solution 
o 8.82 mg BHT + 10 mL EtOH. 
• Tributylamine (TBA) 
o 0.159 g TBA + 10 mL NaOH. 
 
Tissue sample preparation: (The sample preparation applies for both the TBARS and SOD assays) 
 
1. 100 mg of spleen tissue was added to an Eppendorf tube with 1 mL of PBS and homogenized 
thoroughly.  
2. The homogenate was sonicated (Misonixa ultrasonic liquid processor S-4000, Hielscher, 
Germany) for 10 seconds. 
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1. 50 µL of the supernatant, 12.5 µL BHT and 100 µL ortho-phosphoric acid were added into a 
2 mL microfuge tube. 
2. Samples were vortexed for 5 seconds. 
3. 12.5 µL TBA was added to the microfuge tube. 
4. Samples were vortexed for 5 seconds. 
5. Samples were placed in a water bath at 90°C for 45 minutes (made sure there was a hole in the 
lid of the microfuge tube). 
6. Samples were allowed to cool down on ice. 
7. 1 mL butanol and 100 µL saturated salt solution were added to the microfuge tube.  
8. Samples were vortexed for 5 seconds. 
9. The samples were centrifuged (Boeco M240, Hamburg, Germany) at 10000 rpm for one 
minute. 
10. The top pink butanol layer was transferred to a 96-well plate (250 µL per well). 
11. The plate was read at 532 nm in the Multiskan® Spectrum microplate spectrophotometer 
(Thermo Fisher Scientific, Massachusetts, USA). 
 
 
SOD: This assay measures the auto-oxidation of 6-hydroxydopamine (6-HD) at 490 nm for 5 minutes 




• SOD assay buffer: 50 mM NaPO4- without Triton X-100, pH 7.4. 
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• 6-HD: nitrogen purge 10 mL MilliQ water with 50 µL perchloric acid for 15 minutes. Use 10 
mL of this and add 4 mg 6-HD to this solution. Wrap in foil and store on ice. 




1. 12 µL of sample and blank (dH20) were added in triplicate to the 96-well plate. 
2. 15 µL of 6-HD was added to each well. 
3. 170 µL of DETAPAC was added to each well to initiate the reaction. 
4. Absorbance was measured for 5 minutes at 490 nm using a plate reader (EZ Read 400 












Ex vivo heart perfusions 
 
Reagent preparation: 
•  The following five individual buffers were made and kept at 4°C. 
Solution Buffer Amount required 
1 NaCl (119 mM) 279.00 g/ 2 L  
2 NaHCO3 (25 mM) 83.60 g/ 2 L 
3 KCl (4.75 mM) 
KHPO4 (1.2 mM) 
17.60 g/ 1 L 
8.10 g/ 1 L 
4 MgSO4.7H2O (0.6 mM) 
Na2SO4 (0.6 mM) 
7.40 g/ 1 L 
4.20 g/ 1 L 
5 CaCl2.H2O (1.25 mM) 18.00 g/ 1 L  
 
• Krebs Henseleit bicarbonate buffer: 
 
1. 250 mL of solution 1 + 250 of solution 2 + 100 mL of solution 3 + 100 mL of solution 4 
2. 9 g of glucose was added. 
3. After glucose had dissolved, 50 mL of solution 5 was added. 
4. Krebs buffer was gassed with 5% CO2 and 95% O2 to maintain optimal pH  (7.4) and 
oxygenation level. 
 
Animal dissection + heart perfusion 
 
1. The heart was excised and placed in ice-cold Krebs buffer. 
1 L total  
1 L total  
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2. The aortic arch was cut off to make the canula fit properly. 
3. The aorta was placed around top canula and retrogradely perfused (Langendorff) for 15 
minutes. It was secured tightly with thin elastic string. 
4. During the first 15 minutes, excess fat was trimmed off and a side canula was inserted into 
pulmonary vein.  
5. Subsequently,  hearts were switched to the working  mode for another 15 minutes. During this 
time functional parameters were assessed. 
6. Before ischemia was induced, the heart was put back into Langendorff mode. 
7. The left anterior descending coronary artery was thereafter tied off for 35 minutes using silk 
suture. During this period  hearts were kept at 36.8 °C. 
8. To confirm whether the tie was successful, coronary flow should be reduced by approximately 
50%.  
9. After the 35 minutes, the tie was undone and the heart was allowed to perfuse retrogradely for 
10 minutes. 
10. Subsequently,  hearts were switched to the working  mode for 20 minutes to assess the same 
functional parameters. 







• 1% triphenyltetrazolium chloride (TTC): 
§ Solution I: 100 mM NaH2PO42H2O (15.6 g / 1 liter dH20) 
§ Solution II: 100 mM Na2HPO4 (14.2 g / 1 liter dH20) 
§ 2, 3, 5 – triphenyltertazoliumchloride (TTC) 
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1. 20 mL of Solution I + 80 mL of Solution II 
2. pH to 7.4 
3. 5 mL of the above mentioned solution (I + II) and 0.05 g of Tetrazolium salt was used per 
heart (cover in foil as it is light sensitive). 
 
• 10% formaldehyde 
 
Staining and drawing protocol 
 
1. Suture was re-tied at the original  location. 
2. The plastic tube was removed from the top cannula and 0.5 % Evans blue solution was slowly 
injected  (careful to not overstain). 
3. The heart was cut from the cannula and frozen overnight at -20°C. 
4. The heart was then cut from the apex towards the knot (transverse) in five slices. 
5. The five slices of each heart were placed in a plastic tube with the 5 mL of the TTC solution. 
6. Samples were heated for 7 minutes using hands (until infarct and area at risk are easily 
distinguishable). 
7. The TTC was poured off and the formaldehyde solution was added for an hour. 
8. The slices of a sample were then arranged from big to small between two Perspex slides. 
9. The viable tissue (V), area at risk (AR) and infarct zone (I) was sketched onto transparent paper. 
10. The paper was scanned and the image was saved as a ‘’.png’’ file. 
 





1. The scale was set accordingly: “Distance in pixels”, “Known distance” and “Pixel aspect ratio” 
was kept constant throughout the analyses. This doesn’t matter too much, as the result is a 
ratio/percentage, rather than an actual measurement. 
2. Thereafter the free hand tool was used to carefully draw around each of the zones of interest. 
3. The area was calculated for the respective zones. As volume could not be assessed, heart was 
sliced identically in all hearts. And the average of all slices calculated. 
4. The infarct size was calculated as follows: 
!"#$%&'	)*+,	% =	 !(/0 + !) 	× 	100	 
5. The area at risk was calculated as follows: 
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